Exam 3 - Diabetes day 1 jeopardy Flashcards
These are 2 drug classes recommend for DM patients with HTN
ACE-I or ARB’s
This is the class of medication recommended for patients with dyslipidemia
Statins
These are 2 medications that are FDA approved for neuropathy
Lyrica and cymbalta
These are some general rules regarding how we treat the elderly with DM
Less stringent; A1C less than 8; are they able to have help at home, cognitive function, life expectancy
These are common signs and symptoms of hyperglycemia
Polys (polyuria, polydipsia, polyphagia) and fatigue
This is how frequent we need to test a symptomatic patient if all tests are negative
at least every 3 years
to help prevent progression of DM and complications, all patients should do the following
exercise at least 30 min most days of the week, increase fiber, decrease carbs, decrease sugar intake
these are the normal values for A1C fasting glucose, and oral glucose load
A1C < 5.7%
Fasting glucose: <140mg/dL
these are some important points in regards to the differences in how kids/adolescents respond to insulin compared to adults
- changes in insulin sensitivity due to hormone changes
- growth patterns
- supervision at school and daycare
insulin is secreted from this organ and these cells
beta cells from pancreas
asymptomatic patients with a BMI greater than or equal to ___ in adults of any age and who have one or more additional risk factors for DM should be tested
25
we want to prevent infection…this is how we do this
proper vaccinations
these are the diagnostic criteria for A1C, fasting glucose, random glucose and oral glucose tolerance test for DM
A1C: ≥ 6.5%
Fasting glucose: ≥ 126mg/dL
OGT: ≥ 200mg/dL
random glucose + symptoms: ≥ 200mg/dL
these are the diagnostic criteria for A1C, fasting glucose, oral glucose tolerance test for pre-diabetes
A1C: 5.7-6.4%
Fasting glucose: 100-125mg/dL
OGT: ≥ 140-199mg/dL
this type of DM is much more common in US
type 2
this is the goal HTN for a patient with DM (according to the ADA)
< 140/80 and in some cases <130/80 (according to the ADA)
these are 2 oral agents that are not recommended to use in gestational DM
biguainides and TZD’s
in patients that are asymtomatic an do not have any risk factors, this is when you start to test
> age 45
this is the number of people who have DM in the US
~ 25.8 million